ReviewJournal of mammary gland biology and neoplasia2008

From bench to bedside: future potential for the translation of prolactin inhibitors as breast cancer therapeutics.

Charles V Clevenger et al.PubMed ↗Publisher ↗

No numbers read from the abstract.